Clinical Trial: Multicenter, randomized, controlled prospective clinical study comparing sandwich chemoradiotherapy with sequential chemoradiotherapy for newly diagnosed stage II-III extranodal NK/T-cell lymphoma (China)

China, Oct. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Multicenter, randomized, controlled prospective clinical study comparing sandwich chemoradiotherapy with sequential chemoradiotherapy for newly diagnosed stage II-III extranodal NK/T-cell lymphoma'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600134667

Registration Time: 2026/10/19

Type: Interventional study

Primary Sponsor: West China Hospital of Sichuan University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=328067

Published by HT Digital Content Services with permission from Health Daily Digest....